These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18467364)
1. Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. Rogozhin AA; Pang KK; Bukharaeva E; Young C; Slater CR J Physiol; 2008 Jul; 586(13):3163-82. PubMed ID: 18467364 [TBL] [Abstract][Full Text] [Related]
2. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839 [TBL] [Abstract][Full Text] [Related]
3. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions. Comella JX; Molgo J; Faille L Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032 [TBL] [Abstract][Full Text] [Related]
4. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a. Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265 [TBL] [Abstract][Full Text] [Related]
5. Targeting the neuromuscular junction in skeletal muscles. Childers MK Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S38-44. PubMed ID: 15448576 [TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection. Cai BB; Francis J; Brin MF; Broide RS Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376 [TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting. Eleopra R; Tugnoli V; Quatrale R; Gastaldo E; Rossetto O; De Grandis D; Montecucco C Clin Neurophysiol; 2002 Aug; 113(8):1258-64. PubMed ID: 12140005 [TBL] [Abstract][Full Text] [Related]
8. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats. Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109 [TBL] [Abstract][Full Text] [Related]
9. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions. Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945 [TBL] [Abstract][Full Text] [Related]
11. Onset dynamics of type A botulinum neurotoxin-induced paralysis. Lebeda FJ; Adler M; Erickson K; Chushak Y J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):251-67. PubMed ID: 18551355 [TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism. Raghunath A; Perez-Branguli F; Smith L; Dolly JO J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326 [TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin. Wright MC; Cho WJ; Son YJ J Comp Neurol; 2007 Sep; 504(1):1-16. PubMed ID: 17614103 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin. Meunier FA; Colasante C; Faille L; Gastard M; Molgó J Pflugers Arch; 1996; 431(6 Suppl 2):R297-8. PubMed ID: 8739382 [TBL] [Abstract][Full Text] [Related]
15. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. de Paiva A; Meunier FA; Molgó J; Aoki KR; Dolly JO Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3200-5. PubMed ID: 10077661 [TBL] [Abstract][Full Text] [Related]
16. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction. Baskaran P; Thyagarajan B Muscle Nerve; 2014 Aug; 50(2):206-15. PubMed ID: 24218344 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Meunier FA; Lisk G; Sesardic D; Dolly JO Mol Cell Neurosci; 2003 Apr; 22(4):454-66. PubMed ID: 12727443 [TBL] [Abstract][Full Text] [Related]
19. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections. Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004 [TBL] [Abstract][Full Text] [Related]
20. Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Slater CR; Fawcett PR; Walls TJ; Lyons PR; Bailey SJ; Beeson D; Young C; Gardner-Medwin D Brain; 2006 Aug; 129(Pt 8):2061-76. PubMed ID: 16870884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]